Risk of glaucoma in ocular hypertension with and without pseudoexfoliation

Kass, 2002, The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma, Arch Ophthalmol, 120, 701, 10.1001/archopht.120.6.701 Linnér, 1976, Ocular hypertension: the clinical course during ten years without therapy, Acta Ophthalmol (Copenh), 54, 707, 10.1111/j.1755-3768.1976.tb01790.x Kitazawa, 1977, Untreated ocular hypertension, Arch Ophthalmol, 95, 1180, 10.1001/archopht.1977.04450070078004 Lundberg, 1987, Ocular hypertension: a prospective twenty-year follow-up study, Acta Ophthalmol (Copenh), 65, 705, 10.1111/j.1755-3768.1987.tb07067.x Schulzer, 1991, A comparison of treated and untreated glaucoma suspects, Ophthalmology, 98, 301, 10.1016/S0161-6420(91)32296-6 Schuman, 2000, Clin Ther, 22, 167, 10.1016/S0149-2918(00)88478-7 Diggory, 1996, Medical treatment of glaucoma—a reappraisal of the risks, Br J Ophthalmol, 80, 85, 10.1136/bjo.80.1.85 Robin, 2004, The Ocular Hypertension Treatment Study. Intraocular pressure lowering prevents the development of glaucoma, but does that mean we should treat before the onset of disease?, Arch Ophthalmol, 122, 376, 10.1001/archopht.122.3.376 Jampel, 2004, We should treat fewer patients with elevated introcular pressure now that we know the results of the Ocular Hypertension Treatment Study, Arch Ophthalmol, 122, 378, 10.1001/archopht.122.3.378 Gordon, 2002, The Ocular Hypertension Treatment Study: baseline factors that predict the onset of primary open-angle glaucoma, Arch Ophthalmol, 120, 714, 10.1001/archopht.120.6.714 Ritch, 2002, Exfoliation syndrome: more than meets the eye, Acta Ophthalmol Scand, 80, 465, 10.1034/j.1600-0420.2002.800502.x Heijl, 2002, Reduction of intraocular pressure and glaucoma progression, Arch Ophthalmol, 120, 1268, 10.1001/archopht.120.10.1268 Aasved, 1971, Intraocular pressure in eyes with an without fibrillopathia epitheliocapsularis (so-called senile exfoliation or pseudoexfoliation), Acta Ophthalmol (Copenh), 49, 601, 10.1111/j.1755-3768.1971.tb02967.x Ringvold, 1991, The middle-Norway Eye-Screening Study, Acta Ophthalmol (Copenh), 69, 273, 10.1111/j.1755-3768.1991.tb04814.x Mitchell, 1999, The relationship between glaucoma and pseudoexfoliation: the Blue Mountains Eye Study, Arch Ophthalmol, 117, 1319, 10.1001/archopht.117.10.1319 Davanger, 1991, Pseudo-exfoliation, IOP and glaucoma, Acta Ophthalmol (Copenh), 69, 569, 10.1111/j.1755-3768.1991.tb04841.x Ekström, 1993, Elevated intraocular pressure and pseudoexfoliation of the lens capsule as risk factors for chronic open-angle glaucoma: a population-based five-year follow-up study, Acta Ophthalmol (Copenh), 71, 189, 10.1111/j.1755-3768.1993.tb04989.x Høvding, 1986, Prognostic factors in the development of manifest open angle glaucoma: a long-term follow-up study of hypertensive and normotensive eyes, Acta Ophthalmol (Copenh), 64, 601, 10.1111/j.1755-3768.1986.tb00675.x Pohjanpelto, 1986, Influence of exfoliation syndrome on prognosis in ocular hypertension ≥ (greater than or equal to) 25 mm. A long term follow-up, Acta Ophthalmol (Copenh), 64, 39, 10.1111/j.1755-3768.1986.tb06869.x Brooks, 1988, The presentation and prognosis of glaucoma in pseudoexfoliation of the lens capsule, Ophthalmology, 95, 271, 10.1016/S0161-6420(88)33190-8 Åsman, 1992, Evaluation of methods for automated hemifield analysis in perimetry, Arch Ophthalmol, 110, 820, 10.1001/archopht.1992.01080180092034 Åsman, 1992, Glaucoma Hemifield Test: automated visual field evaluation, Arch Ophthalmol, 110, 812, 10.1001/archopht.1992.01080180084033 Leske, 1999, Early Manifest Glaucoma Trial: design and baseline data, Ophthalmology, 106, 2144, 10.1016/S0161-6420(99)90497-9 Epstein, 1989, A long-term clinical trial of timolol therapy versus no treatment in the management of glaucoma suspects, Ophthalmology, 96, 1460, 10.1016/S0161-6420(89)32688-1 Kass, 1989, Topical timolol administration reduces the incidence of glaucomatous damage in ocular hypertensive individuals. A randomized, double-masked, long-term clinical trial, Arch Ophthalmol, 107, 1590, 10.1001/archopht.1989.01070020668025 Ritch, 1994, Exfoliation syndrome: the most common identifiable cause of open-angle glaucoma, J Glaucoma, 3, 176, 10.1097/00061198-199400320-00018 Netland, 1995, Elastosis of the lamina cribrosa in pseudoexfoliation syndrome with glaucoma, Ophthalmology, 102, 878, 10.1016/S0161-6420(95)30939-6 Schlötzer-Schrehardt, 1991, Electron-microscopic identification of pseudoexfoliation material in extrabulbar tissue, Arch Ophthalmol, 109, 565, 10.1001/archopht.1991.01080040133044 Cursiefen, 1997, Das Pseudoexfoliationssyndrom bei Patienten mit retinaler Venenast- und Zentralvenenthrombose, Klin Monatsbl Augenheilkd, 211, 17, 10.1055/s-2008-1035088 Leske, 2003, Factors for glaucoma progression and the effect of treatment: the Early Manifest Glaucoma Trial, Arch Ophthalmol, 121, 48, 10.1001/archopht.121.1.48